Science 'Threatened'

Researchers in Europe are holding their collective breath as a European court tries to decide whether to ban patents on technologies that use human embryonic stem cells, says Veronique Greenwood at the 80beats blog. Scientists warn that if this ban is imposed and labs can no longer make money from their discoveries, regenerative medicine will not go further than the bench, she adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.